AEHR Stock Analysis & AI Grade: HIGH

Aehr Test Systems has emerged as a primary beneficiary of artificial intelligence infrastructure buildout, with a dominant narrative shift from electric vehicle silicon carbide testing toward AI chip validation. The July 14-15 earnings inflection triggered a 40% single-day surge on record bookings and FY27 revenue guidance projecting 160-200% growth, signaling material demand acceleration from hyperscaler capex cycles. The company's non-GAAP EPS beat consensus by $0.12 while revenue climbed 33.4% year-over-year to $18.8M, validating operational execution. Key risks include the July 28 mixed shelf registration filing, which sparked a 5% selloff and raises capital dilution concerns. The earnings reset thesis, while bullish, assumes sustained data center investment momentum that could face cyclical headwinds. Sector tailwinds remain robust, with peers like Teradyne (TER) also benefiting from custom silicon demand. Forward-looking, AEHR's valuation trajectory hinges on backlog conversion and whether the triple-revenue growth thesis materializes without execution stumbles.